Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead
Authors:
- Qing-Yu HeQHQing-Yu He
- Raymond Wai-Yin SunRSRaymond Wai-Yin Sun
- Chi-Ming CheCCChi-Ming Che
- Jen-Fu ChiuJCJen-Fu Chiu
- 1 January 2007
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 554 (2-3) , 113-122
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Structural and Solution Chemistry, Antiproliferative Effects, and DNA and Protein Binding Properties of a Series of Dinuclear Gold(III) Compounds with Bipyridyl LigandsJournal of Medicinal Chemistry, 2006
- Modulation of Cellular Response to Cisplatin by a Novel Inhibitor of DNA Polymerase βMolecular Pharmacology, 2005
- Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details. See http://www.rsc.org/suppdata/cc/b3/b303294a/Chemical Communications, 2003
- In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancerBritish Journal of Cancer, 2002
- Zinc tetraruthenated porphyrin binding and photoinduced oxidation of calf-thymus DNA.Journal of Inorganic Biochemistry, 2000
- Effect of ethidium bromide intercalation on DNA radiosensitivityInternational Journal of Radiation Biology, 2000
- Metal Complexes as Photo- and RadiosensitizersChemical Reviews, 1999
- Antitumor Properties of Some 2-[(Dimethylamino)methyl]phenylgold(III) ComplexesJournal of Medicinal Chemistry, 1996
- The Effect of Co-administered Drugs on Oxaprozin Binding to Human Serum AlbuminJournal of Pharmacy and Pharmacology, 1995
- Reactions of a cisplatin analog bearing an estrogenic 1,2-diarylethylenediamine ligand with sulfur-containing amino acids and glutathioneJournal of Inorganic Biochemistry, 1995